loadpatents
name:-0.044841051101685
name:-0.015127182006836
name:-0.00066685676574707
During; Matthew J. Patent Filings

During; Matthew J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for During; Matthew J..The latest application filed is for "treatment of metabolic-related disorders using hypothalamic gene transfer of bdnf and compositions therefor".

Company Profile
0.13.16
  • During; Matthew J. - Columbus OH US
  • During; Matthew J. - New York NY
  • During; Matthew J. - Philadelphia PA
  • During; Matthew J. - Weston CT
  • During; Matthew J. - Westport CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment of metabolic-related disorders using hypothalamic gene transfer of BDNF and compositions therefor
Grant 9,265,843 - During , et al. February 23, 2
2016-02-23
Infusion device and method for infusing material into the brain of a patient
Grant 8,182,460 - Kaplitt , et al. May 22, 2
2012-05-22
Treatment of Metabolic-Related Disorders Using Hypothalamic Gene Transfer of BDNF and Compositions Therefor
App 20110288160 - During; Matthew J. ;   et al.
2011-11-24
System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
App 20110274718 - During; Matthew J. ;   et al.
2011-11-10
Transcriptional regulation of target genes
Grant 8,021,838 - Kaplitt , et al. September 20, 2
2011-09-20
Method and compositions for modifying target receptor function associated with neurological disorders
Grant 7,935,333 - During May 3, 2
2011-05-03
Compositions And Methods For Skin Care
App 20100221200 - During; Matthew J.
2010-09-02
Infusion Device And Method For Infusing Material Into The Brain Of A Patient
App 20100191218 - Kaplitt; Michael G. ;   et al.
2010-07-29
Methods And Compositions For The Treatment Of Neurological Disease
App 20100168215 - During; Matthew J. ;   et al.
2010-07-01
Methods and compositions for the treatment of neurological disease
Grant 7,723,288 - During , et al. May 25, 2
2010-05-25
Insulin-associated peptides with effects on cerebral health
Grant 7,655,619 - During , et al. February 2, 2
2010-02-02
Transcriptional regulation of target genes
App 20070059290 - Kaplitt; Michael G. ;   et al.
2007-03-15
Infusion device and method for infusing material into the brain of a patient
App 20060129126 - Kaplitt; Michael G. ;   et al.
2006-06-15
Peptide compositions with effects on blood glucose
App 20050222036 - During, Matthew J. ;   et al.
2005-10-06
Methods and compositions for the treatment of neurological disease
App 20050136036 - During, Matthew J. ;   et al.
2005-06-23
Glutamic acid decarboxylase (GAD) based delivery system
Grant 6,780,409 - During , et al. August 24, 2
2004-08-24
Method and compositions for modifying target receptor function associated with neurological disorders
App 20040131596 - During, Matthew J.
2004-07-08
Peptide compositions with effects on cerebral health
App 20040092432 - During, Matthew J. ;   et al.
2004-05-13
Insulin-associated peptides with effects on cerebral health
App 20040014660 - During, Matthew J. ;   et al.
2004-01-22
Transcriptional regulation of target genes
App 20030087264 - Kaplitt, Michael G. ;   et al.
2003-05-08
AAV-mediated delivery of DNA to cells of the nervous system
Grant 6,503,888 - Kaplitt , et al. January 7, 2
2003-01-07
Delivery system for gene therapy to the brain
Grant 6,436,708 - Leone , et al. August 20, 2
2002-08-20
Glutamic acid decarboxylase (GAD) based delivery system
App 20020091094 - During, Matthew J. ;   et al.
2002-07-11
Delivery System For Gene Therapy To The Brain
App 20020076394 - LEONE, PAOLA ;   et al.
2002-06-20
Production of chimeric capsid vectors
App 20020045264 - During, Matthew J. ;   et al.
2002-04-18
Helper functions for recombinant vector production
Grant 6,329,181 - Xiao , et al. December 11, 2
2001-12-11
AAV-mediated delivery of DNA to cells of the nervous system
Grant 6,180,613 - Kaplitt , et al. January 30, 2
2001-01-30
Polymeric device for controlled drug delivery to the CNS
Grant 5,601,835 - Sabel , et al. February 11, 1
1997-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed